Loading…
Chubb Limited
NYSE: CB Financials Insurance 🔎 Screen
S&P 500
🏹 Trader: 🎯 Near 52W High | BRS 64 Forming View all →
$134.6B
Market Cap
12.2
P/E
2.64
PEG
10.9%
ROCE
14.3%
ROE
0.31
D/E
21.8%
OPM
-6.9%
% from 52W High
66
α RS
🔍 CB is showing a high-conviction setup because it matches 8 of 39 tracked screener presets, RS Rating is 66, and it's within 6.9% of its 52-week high. Net: Broad signal stack, not a recommendation. ? Conviction RS Rating 52W High
Sources
Conviction 8/39 · RS Rating 66 · 6.9% from 52W high
⚖️ Compare 🔒 Generate Report 🔒 Research Packet 📚 Guides
🌏 Global Investor Returns
Currency-adjusted total returns for CB including FX impact
🌏
Click 🌏 Returns tab to load data
📈 Price History
Ratio Health
Excellent
Good
Average
Poor
By Category
📊 Sector Averages
About

Chubb Limited provides insurance and reinsurance products worldwide. It operates in six segments: North America Commercial Property and Casualty (P&C) Insurance, North America Personal P&C Insurance, North America Agricultural Insurance, Overseas General Insurance, Global Reinsurance, and Life Insurance. The company offers property and general liability, workers' compensation, and umbrella; professional and management liability; environmental, health, and international coverages; and claims and risk management products and services, loss control, and engineering and complex claims management. It also provides homeowners, automobile and collector cars, valuable articles, and personal and excess liability insurance. In addition, the company offers multiple peril crop insurance and crop-hail insurance for farm, ranch, specialty (P&C), and commercial agriculture products; product and employer liability, business interruption, and specialty risk; property insurance products, including traditional commercial fire coverage, energy industry-related, marine, construction, and other technical coverages; personal accident and supplemental medical coverages, such as accidental death, business/holiday travel, specified disease, disability, medical and hospital indemnity, and income protection; and directors and officers, professional indemnity, cyber, surety, aviation, political risk, and specialty personal lines products. Further, it provides property catastrophe reinsurance; traditional and specialty P&C reinsurance; and protection and savings products, which includes individual and group term life, dental, critical illness, dementia, hospital cash, credit life, group employee benefits, whole life, universal life, unit linked contracts, endowment plans, and annuities. The company was formerly known as ACE Limited and changed its name to Chubb Limited in January 2016. Chubb Limited was incorporated in 1985 and is headquartered in Zurich, Switzerland.

Key Ratios Snapshot
📈 Growth Pattern
📊 Quick Scorecard
Loading…
🔒
Premium Feature
AI-generated 10-section company profile — business model, financials, strengths, risks & management quality
Upgrade to Premium
Already a member? Log in
📐
3-Statement Financial Model
Bear / Base / Bull projections · DCF fair value · Reverse-DCF
Open Model →
🎙 Management Tone Confident Specific → Stable 5 quarters Full tone analysis in Intelligence →
Good quarter Investor Presentation One-Pager? Q2 2026
Net Premiums Written
$14.7B
+3.6% YoY
Core Operating Income
$2.84B
+14.6% YoY
Core Operating EPS
$7.26
+18.2% YoY
Net Income
$2.85B
-3.8% YoY
P&C Combined Ratio
83.8%
Improved vs prior year
What Went Right
  • Record adjusted net investment income of $1.88B, up 11.4% YoY, supported by 5.5% new money yield.
  • P&C underwriting income rose 18.8% to $1.94B with an 83.8% combined ratio.
  • Tangible book value per share up 17.1% YoY; core operating ROTE of 21.2%.
  • Overseas general premiums grew 10.2%, with Latin America +15.6% and Asia +12.0%.
  • Life income up 9% to $332M; International Life premiums and deposits up 14.4%.
What to Watch
  • Softening commercial P&C market — property pricing down 6% and casualty pricing failing to keep pace with loss costs.
  • Large account and E&S property premiums deliberately down 9% due to underwriting actions.
  • London wholesale business actively writing U.S. casualty at terms management views as inadequate.
  • Corporate runoff adverse development of $158M, two-thirds from molestation-related claims.
  • Management broadened EPS growth outlook range due to softening market conditions.
Management Guidance
  • No explicit EPS guidance; Evan Greenberg said he remains confident in strong and potentially double-digit EPS growth over time.
  • Core operating effective tax rate for full-year 2026 expected in range of 19.5%-20%.
  • No specific revenue guidance provided for next quarter.
Investor Lens
The Chubb thesis looks stronger after this call: record investment income, broad-based growth across international, life, and personal lines, and disciplined capital management support double-digit TBV growth. Management's cautious tone on commercial P&C pricing is a real but manageable headwind given the company's diversification and underwriting discipline. The 21.2% core ROTE and 18.2% core EPS growth reinforce the quality compounder narrative.
From investor presentation · AI-generated analysis · Not investment advice
🔒
Premium Feature
Investor Presentation One-Pager — quarterly highlights, what went right/wrong & management guidance
Upgrade to Premium
Already a member? Log in
📈 STRONG Strong quarter: core EPS $7.26, up 18.2%, with record investment income and 83.8% combined ratio.
Revenue
Consolidated net premiums written were $14.7B, up 3.6% YoY. P&C premiums rose 3.0%, life insurance premiums rose 7.5%, and overseas general grew 10.2%, while North America commercial was down 2.3%.
Profitability
Core operating income was $2.84B, up 14.6%, and core operating EPS was $7.26, up 18.2%. Net income was $2.85B, down 3.8% YoY due to adjusted net realized losses comparisons.
Margins
P&C combined ratio improved to 83.8%, with current accident year ex-CAT combined ratio of 82.2%. P&C underwriting income rose 18.8% to $1.94B, driven by strong underwriting and lower catastrophe losses.
Balance Sheet
Invested assets reached $175B, up from $161B a year ago. Book value per share was $195.45, up 12.3% YoY; tangible book value per share was $131.93, up 17.1% YoY. Chubb issued $2.2B debt at 4.2% average cost and repurchased $979M shares in the quarter.
Key Risks
Management flagged softening commercial P&C conditions, particularly property and casualty lines, with casualty loss costs running 6%-7% primary and 9.5%-12% excess. London wholesale and newer MGA/smaller competitors are underpricing U.S. casualty. Financial lines remain soft.
Outlook
No formal quantitative guidance given; management expressed confidence in continued strong operating earnings and double-digit tangible book value growth. Full-year core operating tax rate expected to be 19.5%-20%.
Generated by AI · Q2 2026 results · Not investment advice
🔒
Free Account Required

Create a free Finmagine account to access Finmagine™ Scorecard.

See how this company scores across 5 dimensions — Financial Health, Growth Prospects, Competitive Position, Management Quality, and Valuation — powered by 30+ computed ratios.

Create Free AccountLog In
🔒
Premium Feature

Upgrade to Finmagine Premium to unlock Ask AI.

Get 25 expert AI analysis templates — Business KPIs, Comprehensive, Forensic Governance, Peer Comparison, Risk-Reward, Full Research Report, IPO Decoder, Red Flag Detector, and more — ready to paste into ChatGPT, Claude, Gemini, or Perplexity.

Upgrade to PremiumCreate Free Account
🔒
Premium Feature

Upgrade to Finmagine Premium to unlock Peer Comparison.

Compare this company side-by-side against its sector peers with financial metrics, ratio benchmarking, and relative performance across all key dimensions.

Upgrade to PremiumCreate Free Account
✓ 📞 Earnings Call Transcripts (5 quarters) submit a missing quarter
🔍
🔎 See cross-company document search → ?
📞 Earnings Call Transcripts (5)
Q2 2026 Q2 2026 2026-07-22
Core operating earnings rose 14.6% year-over-year to $2.8 billion, with strong P&C underwriting, investment, and life income. Despite softening market conditions and rising loss costs in casualty, diversified growth and disciplined underwriting support continued EPS and tangible book value growth.
Q1 2026 Q1 2026 2026-04-22
Q1 saw robust growth in premiums, earnings, and book value, with strong underwriting and investment results. Management remains confident in continued double-digit EPS and tangible book value growth, despite macro and market uncertainties.
Q4 2025 Q4 2025 2026-02-04
Record earnings and premium growth were achieved in 2025, driven by strong underwriting, investment income, and diversified global operations. Digital transformation and disciplined capital allocation support a positive outlook for 2026, despite CAT and FX risks.
Q3 2025 Q3 2025 2025-10-22
Record quarterly results with core operating income up 29% and EPS up 31% year-over-year, driven by strong underwriting, investment income, and broad-based premium growth. Tangible book value per share rose 17%, and capital returns to shareholders increased, with continued focus on disciplined growth and digital transformation.
Q2 2025 Q2 2025 2025-07-23
Record quarterly results with core operating EPS up 14% and broad-based premium growth across all regions. Strong underwriting, investment income, and disciplined capital management supported tangible book value growth and robust returns, despite macroeconomic and litigation headwinds.
🔒
Premium Feature

Upgrade to Finmagine Premium to unlock Catalyst Timeline.

Every result, order win, insider trade, ECS update, earnings-call, and SEC announcement for this company — in one chronological lane.

Upgrade to PremiumCreate Free Account
🔒
Premium Feature

Upgrade to Finmagine Premium to unlock Full Report.

Read the complete Finmagine™ investment research report — comprehensive fundamental analysis, business model assessment, competitive positioning, and investment recommendation.

Upgrade to PremiumCreate Free Account

📊 Analysis Methodology

This comprehensive investment analysis was conducted using The Finmagine™ Stock Analysis & Ranking Methodology, a proprietary framework that systematically evaluates stocks across five critical dimensions: Financial Health, Growth Prospects, Competitive Positioning, Management Quality, and Valuation.

🎯
Discover Our Proven Investment Framework Learn how we analyze and rank stocks using advanced quantitative models, multi-dimensional scoring systems, and dynamic discriminatory ranking techniques that have guided successful investment decisions across market cycles.
📊 Explore The Finmagine™ Methodology

A comprehensive, bias-free framework for analyzing and ranking stocks by Financial Strength, Growth Potential, Competitive Edge, Management Quality, and Value.

Financial Model
Projections are built from each company's audited annual financials (Income Statement, Balance Sheet, Cash Flow) over the last 5 fiscal years. Forward assumptions — revenue growth %, EBITDA margin, D&A (USD millions), interest expense, tax rate, and capex — are AI-generated using historical context and refreshed twice a year: after the December results season and after the September/Q4 results season.

DCF Valuation
Fair Value = Σ(FCFt / (1+WACC)t) + Terminal Value. Terminal Value uses the Gordon Growth Model: FCF5 × (1+g) / (WACC−g). Default WACC: 10% (US risk-free ~4.5%, equity risk premium ~5.5%). Default terminal growth: 3% (long-run US nominal GDP proxy).

CAGR Tracker
Expected 5-year CAGR = (DCF Fair Value / Current Price)1/5 − 1. Assumes fair value is reached in exactly 5 years — a mechanical estimate only.

Data Sources & Limitations
Financial statements sourced from public filings. Prices updated daily. Forward assumptions are AI-generated. All monetary values in USD millions. Non-US ADR companies may have currency conversion inaccuracies. Models are point-in-time and do not update intra-quarter or account for M&A, macro shocks, or extraordinary items.

⚠️ Important Disclaimers — Please read without fail.

Investment Risk:
Investing in securities, including US equities and ETFs, involves inherent risks including the potential loss of principal. All investments are subject to market fluctuations, economic conditions, regulatory changes, and other factors that may affect their value. Past performance is not indicative of future results. This analysis is provided for informational and educational purposes only and should not be construed as investment advice under any circumstances.

No Investment Recommendation:
This analysis does not constitute, nor should it be interpreted as, an offer, solicitation, or recommendation to buy, sell, or hold any securities or financial products. Investors are strongly advised to conduct their own independent research and due diligence and to consult with a licensed financial advisor or an SEC-registered investment adviser before making any investment decisions, taking into account their individual financial situation, risk tolerance, and investment objectives.

Not SEC-Registered:
Finmagine is not registered as an investment adviser with the U.S. Securities and Exchange Commission (SEC) or any state securities authority. Nothing on this platform constitutes investment advice as defined under the Investment Advisers Act of 1940.

Conflict of Interest Disclosure:
The author and/or analyst may currently hold or have previously held positions in the securities discussed. Any such positions are not intended to influence the objectivity or independence of the analysis. This research is produced independently and is not sponsored, endorsed, or commissioned by any company or institution.

Information Sources:
The analysis is based on publicly available information including SEC filings (10-K, 10-Q), annual reports, management commentary, and publicly available financial data. Information is believed to be accurate as of the date of publication but may be subject to change without notice. Readers are encouraged to independently verify all information before acting upon it.

Forward-Looking Statements:
This analysis may contain forward-looking statements, forecasts, or projections that are inherently subject to risks, uncertainties, and assumptions. Actual results may differ materially from those expressed or implied. Finmagine does not undertake any obligation to update such statements in the future.

Limitation of Liability:
The content is provided "as is" without any warranties, express or implied. Finmagine expressly disclaims any liability for errors, omissions, or any losses incurred as a result of reliance on the information provided. Readers assume full responsibility for their investment decisions.